When it comes to promoting innovative ideas in the field of life sciences within Charité – Universitätsmedizin Berlin and its partner institutions, Stiftung Charité has been an important authority since its establishment in 2005. The private,…
It’s not difficult to come across start-ups and young companies in the capital region. Berlin-Brandenburg boasts a diverse and steadily growing start-up ecosystem. And financing options are just as diverse as this ecosystem, encompassing various…
Karen Christman, a Stiftung Charité Visiting Fellow at the Max Delbrück Center, is among the first researchers to have won a Humboldt Research Award under Germany’s Global Minds Initiative. The award will enable her to expand her research in Germany…
The Max Delbrück Center has recently completed construction of a new Demonstrator Lab as a testbed to reduce the environmental impact of biomedical research. The insights gained will be applied to all new building renovations across the center.
A team of researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center has captured the fleeting moment a nerve cell releases its neurotransmitters into the synaptic cleft. Their microscopic images and description of the process…
Neurons in the cerebral cortex form subtypes that differ in function and connectivity
Take your chance to pitch at the 𝗙𝗲𝗺𝗮𝗹𝗲𝗖𝗮𝗽𝗶𝘁𝗮𝗹 𝗽𝗶𝘁𝗰𝗵 𝗲𝘃𝗲𝗻𝘁 on 𝗝𝗮𝗻𝘂𝗮𝗿𝘆 𝟮𝟬, 𝟮𝟬𝟮𝟲 in 𝗕𝗲𝗿𝗹𝗶𝗻 – directly in front of a room full of women investors and those who aspire to become one.
HTGF, B. Braun Innovation Hub, B. Braun Stiftung and Dräger are organizing the MEDTECH PITCH DAY 2026 on 17 March 2026 in Freiburg.
Deadline: January 15th, 2026
- Dr. Reddy’s receives exclusive rights to develop and commercialise Eftilagimod Alfa in all countries outside North America, Europe, Japan, and Greater China
- Under the terms, Immutep to receive upfront payment of USD 20 million (~AUD 30.2…
